Project Overview
Eniware, LLC is a mission-driven medical technology company focused on solving a critical global health challenge: infection control in resource-limited environments. Founded in 2011, Eniware offers a groundbreaking portable, power-independent sterilization solution using patented nitrogen dioxide (NO₂) gas technology. Designed for use in rural clinics, disaster zones, and conflict areas—where access to electricity and conventional sterilization methods is limited—Eniware’s platform ensures that sterile surgical tools are accessible anywhere, at any time. With exclusive licensing rights across Africa, Asia (excluding Japan), and the Middle East, Eniware is redefining sterilization in global healthcare. Sleem Hasan advised Eniware in its efforts to scale globally, align with humanitarian stakeholders, and strengthen investment narratives around health equity and impact.
Key Objectives
Position Eniware as a Global Health Enabler
Establish Eniware’s technology as essential infrastructure in the global movement to reduce surgical infections in low-resource settings.Support Market Access Across Developing Regions
Guide the company’s entry into health systems and humanitarian supply chains in Africa, Asia, and the Middle East.Refine Impact-Driven Investment Narrative
Frame Eniware’s dual opportunity: global impact + scalable licensing models for MedTech and disaster response.Enable Strategic Partnerships in Public & Military Health
Support outreach to NGOs, governments, and military procurement programs for adoption at scale.
Our Approach
1
Strategic Framing
Healthcare Equity Narrative: Positioned Eniware as a scalable solution for reducing preventable infections in underserved health systems.
Market-Specific Messaging: Helped tailor positioning for each region, aligning with government health priorities and donor agendas.
2
Commercial & Licensing Support
Channel Strategy: Identified pathways for distribution through NGOs, intergovernmental agencies, and public-private partnerships.
Use Case Diversification: Expanded narrative to include military field hospitals, disaster relief, and mobile surgical units.
3
Investor Readiness
Impact-Driven Deck Development: Co-developed materials that bridge MedTech innovation with a global health impact thesis.
Blended Capital Strategy: Advised on aligning with health-focused VCs, foundations, and development financing sources.
4
Founding Team Advisory
Global Growth Mentorship: Offered guidance on expansion, local partnership structuring, and regulatory navigation in emerging markets.
Mission Alignment: Ensured commercial planning remained anchored in Eniware’s core purpose: safe surgery for all.